REFERENCES
- Carrieri M P, Amass L, Lucas G M, Vlahov D, Wodak A, Woody G E. Buprenorphine use: The international experience. Clinical Infectious Disease 2006; 43: S197–215
- World Health Organization, Available at: http://mednet3.who.int/EMlib/ WHO essential medicines library. Accessed 1 June, 2007
- Miro J M, Moreno A, Mestres C A. Infective endocarditis in intravenous drug abusers. Curr Infect Dis Rep 2003; 5(4)307–316
- Martinez E A, Hartsfield S M, Melendez L D, Matthews N S, Slater M R. Cardiovascular effects of buprenorphine in anesthetized dogs. Am J Vet Res 1997; 58(11)1280–1284
- Sganzerla P, Cipolla C, Della Bella P, Fabbiocchi F, Grazi S, Rimondini A, Guazzi M D. Analgesic and hemodynamic effects of buprenorphine in acute infarction of the heart. Jpn Heart J. 1987; 28(1)63–71
- Reves J G, Fragen R J, Vinik H R, Greenblatt D J. Midazolam: Pharmacology and Uses. Anesthesiology 1985; 62: 310–324